跳至主要内容
临床试验/IRCT20190626044030N1
IRCT20190626044030N1招募中3 期

Evaluation the Effect of N-acetylcysteine on Inflammatory Biomarkers and Disease Activity Score (DAS28-ESR) of Rheumatoid Arthritis

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 76 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Rheumatoid arthritis patients with a DAS28-ESR score>=2.6
  • No history of consuming antioxidant supplements within last 2 months
  • No change of the type and dose of patient's drugs in the last 1 month
  • No recent infectious disease
  • Patients that are under treatment with DMARDs

排除标准

  • Biologic agents therapy in the last 6 months
  • Patients with concurrent autoimmune, rheumatoid disease and gout
  • Using other complementary and alternative medicine
  • Pregnancy and lactation
  • Any addiction to psychotropic agents and opioids
  • Uncontrolled hypertension
  • Active gastrointestinal ulcer
  • History of severe skin allergy
  • Consuming nitroglycerin

研究者

相似试验